highperformr logo

Aitia's Overview

Total employees120
HeadquartersCambridge
Founded2000

Aitia, which rebranded from GNS Healthcare in May 2023, is a pioneering company in the application of Causal AI and simulation technology to transform drug discovery and development. Aitia develops 'Gemini' Digital Twins—mechanistic, in-silico patient models that simulate disease progression and drug responses at an individual level. This cutting-edge approach enables biopharmaceutical partners to discover novel drug targets, predict patient responses, optimize clinical trial designs, and accelerate the delivery of personalized medicines. Aitia's primary focus areas include oncology, immunology, and neurodegenerative diseases, aiming to de-risk R&D and bring effective therapies to patients more rapidly.

Where is Aitia's Headquarters?

HQ Function

Serves as the company's primary center for research, development of its Causal AI platform and Gemini Digital Twins, client engagement, and overall corporate strategy and operations.

Notable Features:

State-of-the-art office space situated in Kendall Square, fostering collaboration and innovation. The location provides unparalleled access to leading academic institutions, research hospitals, and a vibrant biotech ecosystem.

Work Culture:

Aitia cultivates a highly scientific, innovative, and collaborative work culture. The team is driven by a shared mission to transform patient outcomes through data-driven discoveries. There is a strong emphasis on interdisciplinary teamwork, intellectual curiosity, and translating complex science into impactful healthcare solutions.

HQ Significance:

The Cambridge headquarters is central to Aitia's identity and mission, housing the core talent and technology that drive its advancements in AI-powered drug discovery. Its location in a premier biotech hub facilitates key partnerships and talent acquisition.

Values Reflected in HQ: The headquarters' environment reflects Aitia's core values of scientific rigor, innovation, collaboration, and a patient-centric approach to advancing medicine.

Location:

While its physical operations are centered in Cambridge, MA, Aitia's influence and collaborations are global. The company partners with major biopharmaceutical companies, academic research centers, and healthcare systems across North America, Europe, and Asia. Its Causal AI platform and Gemini Digital Twins are applied to diverse therapeutic areas and patient populations worldwide, supporting global efforts in drug discovery and precision medicine.

Street Address:

One Main Street, 13th Floor

City:

Cambridge

State/Province:

MA

Country:

USA

Aitia's Global Presence

Buying Intent Signals for Aitia

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Aitia

As of April 2025, Aitia' leadership includes:

Colin Hill - Co-founder & Chief Executive Officer
Iya Khalil, PhD - Co-founder & Chief Commercial & AI Officer
Jedd D. Wolchok, MD, PhD - Chief Medical Officer
Jason Bobay - Chief Financial Officer

Investors of Aitia

Aitia has been backed by several prominent investors over the years, including:

Amgen Ventures
Celgene (now Bristol Myers Squibb)
Echo Health Ventures
Alexandria Venture Investments
Cambia Health Solutions
Horizon Blue Cross Blue Shield of New Jersey
Mitsui & Co. Global Investment, Inc.
UnitedHealth Group
RTW Investments, LP

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Aitia has focused on strengthening its executive team to support its growth and leadership in AI-driven drug development, highlighted by a key strategic hire in medical leadership.

New Appointments:

Jedd D. Wolchok, MD, PhD, Dr. Jedd D. Wolchok joined Aitia as Chief Medical Officer, bringing extensive expertise in oncology and clinical research to guide the company's medical strategy.

Technology (Tech Stack) used by Aitia

Discover the tools Aitia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Aitia Email Formats and Examples

Aitia (formerly GNS Healthcare) likely uses common corporate email formats for its employees. The most probable patterns involve combinations of first name, last name, or initials followed by '@aitia.com'.

[first_initial][last]@aitia.com (e.g., jdoe@aitia.com) and [first].[last]@aitia.com (e.g., jane.doe@aitia.com)

Format

chill@aitia.com

Example

80%

Success rate

News and media

Business WireOctober 17, 2023

Aitia Announces Appointment of Dr. Jedd Wolchok as Chief Medical Officer

Aitia appointed Dr. Jedd D. Wolchok, a leading figure in immuno-oncology, as its Chief Medical Officer. He will spearhead the company's clinical strategy and leverage his expertise to advance Aitia's causal AI-driven drug development programs....more

Business WireMay 23, 2023

GNS Rebrands as Aitia, Pioneering the Next Generation of Causal AI to Power Drug Discovery and Development

GNS Healthcare announced its corporate rebrand to Aitia. The new name and brand identity reflect the company's evolution and singular focus on Causal AI and Gemini Digital Twins to discover the next generation of breakthrough drugs and accelerate their development....more

Business WireMarch 14, 2023

GNS Healthcare (now Aitia) and Daiichi Sankyo Announce Research Collaboration to Power Novel Drug Discovery with Causal AI and In Silico Patients

GNS Healthcare (now Aitia) and Daiichi Sankyo initiated a research collaboration to utilize GNS's REFS™ Causal AI and simulation platform. The partnership aims to discover novel therapeutic targets and create new patient stratification biomarkers, initially focusing on key oncogenic pathways....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Aitia, are just a search away.